Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-23-042480

EVP, Chief Operating Officer gave up 2,012 shares (to pay taxes)

  • EVP, Chief Operating Officer acquired 5,814 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Szekeres David Leslie EVP, Chief Operating Officer 2023-07-13 Option exercise +1,250 31,202 D
Szekeres David Leslie EVP, Chief Operating Officer 2023-07-13 Option exercise +4,564 35,766 D
Szekeres David Leslie EVP, Chief Operating Officer 2023-07-13 Shares withheld for taxes −2,012 $1.31 $2,636 33,754 D
Derivatives
Szekeres David Leslie EVP, Chief Operating Officer 2023-07-13 Option exercise · Restricted Stock Units −1,250 6,250 D
Szekeres David Leslie EVP, Chief Operating Officer 2023-07-13 Option exercise · Restricted Stock Units −4,564 23,372 D
Loading xslF345X05/doc4.xml…